BioAge Labs Inc’s filing revealed that its Director Pande Vijay Satyanand acquired Company’s shares for reported $2.5 million on Oct 01 ’24. In the deal valued at $19.73 per share,126,793 shares were bought. As a result of this transaction, Pande Vijay Satyanand now holds 1,026,793 shares worth roughly $4.39 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Pande Vijay Satyanand bought 67,096 shares, generating $1,323,804 in total proceeds. Upon buying the shares at $19.73, the Director now owns 1,093,889 shares.
Before that, Pande Vijay Satyanand bought 25,306 shares. BioAge Labs Inc shares valued at $503,589 were divested by the Director at a price of $19.90 per share. As a result of the transaction, Pande Vijay Satyanand now holds 1,119,195 shares, worth roughly $4.79 million.
Morgan Stanley downgraded its BioAge Labs Inc [BIOA] rating to an Underweight from a an Overweight in a research note published on December 10, 2024; the price target was decreased to $5 from $40. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in early December from “a Buy” to “a Hold”. Citigroup also remained covering BIOA and has decreased its forecast on December 09, 2024 with a “Neutral” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on October 21, 2024. It rated BIOA as “an Overweight”.
Price Performance Review of BIOA
On Friday, BioAge Labs Inc [NASDAQ:BIOA] saw its stock fall -6.75% to $4.28. Over the last five days, the stock has lost -78.70%. BioAge Labs Inc shares have fallen nearly -76.62% since the year began.
Levels Of Support And Resistance For BIOA Stock
The 24-hour chart illustrates a support level at 4.08, which if violated will result in even more drops to 3.89. On the upside, there is a resistance level at 4.63. A further resistance level may holdings at 4.98. The Relative Strength Index (RSI) on the 14-day chart is 21.51, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -9.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.69%. Stochastics %K at 2.02% indicates the stock is a buying.
How much short interest is there in BioAge Labs Inc?
A steep rise in short interest was recorded in BioAge Labs Inc stocks on 2024-11-29, growing by 0.17 million shares to a total of 2.37 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.21 million shares. There was a rise of 7.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 21, 2024 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $42 price target.
